Related by context. All words. (Click for frequent words.) 77 neuroendocrine cancers 76 carcinoid tumors 73 carcinoid tumor 73 renal cell carcinomas 72 neuroendocrine tumors 71 seminomas 71 pheochromocytoma 70 ependymomas 70 pulmonary metastases 70 Chronic lymphocytic leukemia 70 sarcomatoid 70 MGUS 70 ADPKD 70 epithelial tumors 70 mucinous 70 breast carcinomas 70 basal cell carcinoma BCC 70 osteosarcomas 70 essential thrombocythemia 69 nonmelanoma skin cancers 69 adenocarcinomas 69 renal tumors 69 pancreatic adenocarcinoma 69 Papillary 69 Cholangiocarcinoma 69 GISTs 69 metastatic neuroendocrine tumors 69 colorectal carcinoma 69 supratentorial 68 liver metastasis 68 epithelioid 68 metastatic lesions 68 hematologic disorders 68 squamous cell lung cancer 68 myelofibrosis polycythemia vera 68 Glioblastoma multiforme 68 Acute myeloid leukemia 68 serous ovarian cancer 68 lung adenocarcinomas 68 paraganglioma 68 neoplasm 68 meningiomas 68 liver metastases 68 Glioblastoma 68 oligodendrogliomas 68 Histologically 68 hematological diseases 68 Gliomas 68 lymphocytic leukemia 68 carcinoids 68 thyroid nodules 68 ductal adenocarcinoma 68 astrocytomas 68 gastric adenocarcinoma 68 allogeneic HSCT 68 esophagogastric junction 68 adenomatous 68 leukaemias 68 ANCA associated 68 malignant pleural mesothelioma 68 gastric carcinoma 68 glomerulonephritis 68 gastrointestinal stromal tumor 67 anaplastic 67 cystic lesions 67 antiangiogenic therapy 67 pulmonary metastasis 67 Sjögren syndrome 67 infarcts 67 cholangiocarcinoma 67 Leukemias 67 mycosis fungoides 67 breast carcinoma 67 thymoma 67 prostate carcinoma 67 PCNSL 67 Basal cell 67 leukemia AML 67 hepatocellular carcinomas 67 lymphocytic 67 Hurthle cell 67 neoplastic 67 Wilms tumors 67 EGFR inhibitors 67 lobular carcinoma 67 Candida infection 67 vestibular schwannomas 67 molecular subtypes 67 peritoneal carcinomatosis 67 leiomyosarcoma 67 neuroendocrine carcinoma 67 leiomyomas 67 myeloproliferative diseases 67 differentiated thyroid 67 tumoral 66 urothelial cancer 66 pancreatic NET 66 nodular melanoma 66 leukoencephalopathy 66 GIST tumors 66 Glioblastoma multiforme GBM 66 Carcinoid tumors 66 breast pancreatic 66 papillary carcinoma 66 histologies 66 K ras mutations 66 thymic carcinoma 66 Squamous 66 paragangliomas 66 nonsmall cell lung cancer 66 ccRCC 66 Glioma 66 hamartomas 66 choriocarcinoma 66 familial ALS 66 cisplatin resistant 66 unresectable tumors 66 medically inoperable 66 metastatic tumors 66 sarcomas 66 pituitary adenomas 66 Myelodysplastic syndromes MDS 66 neoplastic cells 66 Anaplastic 66 lymphoproliferative disorder 66 autoimmune hemolytic anemia 66 lung metastasis 66 benign neoplasms 66 myelomas 66 node metastases 66 prostate carcinomas 66 malignant neoplasm 66 Medullary thyroid cancer 66 squamous 66 premalignant 66 malignant lymphoma 66 lymphatic tissue 66 neoplasms 66 follicular lymphomas 66 immunocompetent 66 Cryptococcus neoformans 66 HER2 positive cancers 66 Wegener granulomatosis 66 primary hyperparathyroidism 66 Myelodysplastic Syndrome 66 bone metastasis 66 Systemic lupus erythematosus 66 KRAS mutations occur 65 Relapsing remitting MS 65 Glioblastoma Multiforme GBM 65 myeloproliferative disorders 65 monoclonal gammopathy 65 bladder cancers 65 complement inhibitor eculizumab 65 Gleevec resistant 65 cervical lymph nodes 65 lymphoma subtypes 65 allogeneic bone marrow 65 Endometrial cancer 65 molecular abnormalities 65 gastric cancers 65 metastatic lymph nodes 65 recurrent glioblastoma 65 kidney urologic 65 adrenocortical cancer 65 brain lesions 65 Hepatocellular Carcinoma HCC 65 distant metastasis 65 squamous cell carcinoma SCC 65 histological subtype 65 pancreatic neuroendocrine tumors 65 SSc 65 histologic subtype 65 malignant pancreatic 65 nodal metastasis 65 nasopharyngeal carcinoma 65 urothelial carcinoma 65 EGF receptors 65 papillary renal cell carcinoma 65 Acoustic neuromas 65 angiosarcoma 65 pleural mesothelioma 65 malignant pheochromocytoma 65 oligodendroglioma 65 smoldering myeloma 65 herpesviruses 65 leiomyoma 65 MALT lymphoma 65 cell carcinoma 65 TTR amyloidosis 65 hyperacute 65 gefitinib Iressa 65 Acute myeloid leukemia AML 65 T1a 65 Chronic pancreatitis 65 prostate adenocarcinoma 65 hyperplastic 65 teratoma 65 breast endometrial 65 HBeAg negative 65 CYT# potent vascular disrupting 65 pilocytic astrocytomas 65 extramedullary 65 neoplastic lesions 65 Meningiomas 65 Epstein Barr virus EBV 65 metastatic lung cancer 65 malignant lesions 65 metachronous 65 renal carcinoma 65 paraneoplastic 65 Venous thromboembolism 65 lacunar 65 alveolar rhabdomyosarcoma 65 grade cervical intraepithelial 65 artery stenosis 65 grade gliomas 65 hepatocellular cancer 65 pleomorphic 65 prostate cancer CaP 65 Waldenstrom macroglobulinemia 65 HER2 overexpression 65 hepatocellular carcinoma 64 transfusion syndrome 64 AA amyloidosis 64 KRAS oncogene 64 Hashimoto thyroiditis 64 sCJD 64 systemic amyloidosis 64 metaplasia 64 AA Amyloidosis 64 genitourinary cancers 64 B7 H3 64 infective endocarditis 64 idiopathic myelofibrosis 64 imatinib Gleevec 64 pancreatic carcinoma 64 cytopenias 64 thyrotoxicosis 64 MGd 64 recurrent glioblastoma multiforme 64 prognostic markers 64 synovial sarcoma 64 nasopharyngeal cancer 64 endometrial cancers 64 skeletal metastases 64 histological subtypes 64 lung carcinomas 64 EGFR mutations 64 Glioblastoma Multiforme 64 anterior uveitis 64 pyelonephritis 64 pediatric acute lymphoblastic 64 neurofibromas 64 cardiac dysfunction 64 colorectal liver metastases 64 BCR ABL mutations 64 familial pancreatic cancer 64 seminoma 64 Eisenmenger syndrome 64 JMML 64 acute leukemias 64 schwannomas 64 incidentalomas 64 hematopoietic cell 64 systemic scleroderma 64 breast cancer subtypes 64 proliferative disorders 64 MYCN amplification 64 leukemia ALL 64 mTOR inhibitors 64 metastatic lesion 64 operable breast cancer 64 lymphocytosis 64 RNAi therapeutic targeting 64 lobular carcinomas 64 ovarian carcinoma 64 neurological manifestations 64 degenerative neurological diseases 64 fibrotic disease 64 prostate cancer PCa 64 Diabetic neuropathy 64 LHRH receptor positive 64 EBV infection 64 pancreatic islet cell 64 metastatic gastric 64 Systemic lupus erythematosus SLE 64 ARVD 64 demyelinating disease 64 premalignant lesions 64 hepatocellular carcinoma HCC 64 Metastatic 64 malignant lymphomas 64 ependymoma 64 invasive ductal 64 lobular cancer 64 gastrointestinal stromal tumors 64 cisplatin chemotherapy 64 epithelial cancers 64 clinicopathologic 64 metastatic colorectal 64 histologic subtypes 64 leukemia lymphomas 64 NSCLC tumors 64 pericardial effusion 64 immunodeficiency disorders 64 haematologic 64 testicular cancers 64 bladder ovarian 64 astrocytoma 64 mesotheliomas 64 fatal neuromuscular disorder 64 airway hyperresponsiveness 63 atypical hyperplasia 63 PAOD 63 angiographically 63 neuroblastomas 63 ALK mutations 63 HIV HCV coinfected 63 lichen planus 63 pancreatic endocrine 63 atypical hemolytic uremic syndrome 63 embryonal rhabdomyosarcoma 63 medulloblastomas 63 intracranial tumors 63 malignant growths 63 ductal carcinomas 63 cell carcinomas 63 Aortic stenosis 63 endometrial hyperplasia 63 ovarian tumors 63 intra abdominal abscess 63 glioblastoma tumors 63 papillary 63 malignant ascites 63 p# biomarker 63 fibroadenomas 63 neuroblastoma tumors 63 Pseudomonas aeruginosa infections 63 thyroid carcinoma 63 Ankylosing spondylitis 63 Squamous cell 63 bronchogenic carcinoma 63 acute myeloid 63 malignant fibrous histiocytoma 63 adenomatous polyps 63 candidemia 63 bile duct cancers 63 GBM tumors 63 gastrointestinal malignancies 63 myxoma 63 nonmelanoma 63 monogenic 63 myeloproliferative 63 ductal breast cancer 63 renal fibrosis 63 hemophagocytic lymphohistiocytosis 63 Follicular lymphoma 63 Azedra 63 locoregional 63 MPGN 63 Carcinoid 63 dyskeratosis congenita 63 histopathologic findings 63 Inflammatory bowel diseases 63 gastrointestinal stromal tumors GIST 63 cediranib 63 Sezary syndrome 63 Brain metastases 63 eosinophilic 63 hyperparathyroidism 63 relapsed MM 63 Cell Lymphoma 63 intestinal polyps 63 ductal cancer 63 neurologic complications 63 flavopiridol 63 metastatic uveal melanoma 63 colorectal adenocarcinoma 63 Pulmonary hypertension 63 preoperative chemotherapy 63 malignancies 63 precancerous condition 63 malignant nodules 63 ovarian lung 63 Myelofibrosis 63 FLT3 63 CP CPPS 63 Brugada syndrome 63 neoplasias 63 Radiofrequency ablation 63 biliary strictures 63 Langerhans cell histiocytosis 63 leukemias lymphomas 63 Legg Calvé Perthes disease 63 Virulizin ® 63 LVNC 63 anti angiogenic agents 63 chronic HBV infection 63 Inhaled nitric oxide 63 Leydig cell 63 locoregional recurrence 63 tumor histology 63 pancreatic neuroendocrine 63 metastases 63 Metastatic breast cancer 63 intestinal metaplasia 63 arterial calcification 63 vasculopathy 63 underwent resection 63 sinonasal 63 Basal cell carcinoma 63 basal cell nevus syndrome 63 lysosomal storage disease 63 granulomatous 63 Adenomas 63 pre malignant lesions 63 metastatic malignant melanoma 63 enteroviral infection 63 PARP inhibition 63 metastatic melanomas 63 chronic myeloid 63 PNET 63 Carcinoma 63 cell lymphoma ALCL 63 HER2 positivity 63 plexiform 63 mutated KRAS 63 calculi 63 atherosclerotic disease 63 metastatic liver 63 hypereosinophilic syndrome 63 IgA deficiency 63 LHRH agonists 63 lung lesions 63 INCB# [003] 63 progressive neurodegenerative disorder 63 untreated celiac disease 63 EGFR mutation positive 63 uterine tumors 63 coronary lesions 63 Thrombocytopenia 63 EGFR blockers 63 Medulloblastoma 63 Polycythemia vera 63 polycythemia vera PV 63 recurrent glioblastoma multiforme GBM 63 neuro degenerative disorder 63 antiphospholipid syndrome 63 hamartoma 63 Pleural mesothelioma 63 systemic lupus erythematosus SLE 63 vWD 63 transplantation HCT 63 Circulating tumor cells 63 receptor tyrosine kinase inhibitor 63 micrometastases 63 Hematologic 63 HER2 receptor 63 chronic granulomatous disease 63 Ribavirin causes 63 CMV infection 63 GBMs 63 membranous nephropathy 63 demyelinating 63 histopathologic examination 63 hepatocellular carcinoma liver 63 polypoid 62 radiochemotherapy 62 azacytidine 62 solid organ transplantation 62 Myelodysplastic syndrome 62 orchitis 62 lymphoid cells 62 colorectal cancer CRC 62 myelodysplastic syndrome MDS 62 hematopoietic cancers 62 Metastases 62 myopathies 62 carcinoma HCC 62 aortic dissections 62 post transplant lymphoproliferative 62 lymphoproliferative disorders 62 erythema nodosum 62 Colon polyps 62 atherosclerotic lesions 62 S. maltophilia 62 glial tumors 62 Malignant tumors 62 hereditary predisposition 62 lymph node metastases 62 Lung transplantation 62 lymphomas 62 cytopenia 62 metastatic malignant 62 epilepsies 62 metastatic cancers 62 metastatic cancer 62 autonomic dysfunction 62 coronary stenoses 62 basal cell carcinomas 62 hepatorenal syndrome 62 Enzastaurin 62 HCV infections 62 IL 1ß 62 benign polyps 62 node metastasis 62 intraepithelial 62 Mucositis 62 thoracoscopic lobectomy 62 deacetylase inhibitors 62 neuropathies 62 fibroma 62 ADAM# 62 TTR gene 62 myeloproliferative neoplasms 62 Cutaneous T 62 renal allograft 62 motor neuron degeneration 62 Recurrences 62 pancreatic cancers 62 prognostic indicator 62 neurofibroma 62 graft dysfunction 62 oral FTY# 62 PTLD 62 diffuse intrinsic pontine glioma 62 sonographic diagnosis 62 nonmetastatic 62 rheumatologic 62 occlusive disease 62 unknown etiology 62 CTAP# Capsules 62 juvenile idiopathic arthritis 62 GBA mutations 62 gastrointestinal stromal tumor GIST 62 Acute lymphoblastic leukemia 62 highly vascularized 62 choroidal melanoma 62 biliary tract cancer 62 Helicobacter infection 62 Basal Cell 62 endobronchial 62 demyelination 62 Bezielle 62 malignant prostate 62 splenic 62 Niemann Pick disease 62 pre cancerous lesion 62 Prognostic factors 62 ATTR CM 62 benign proliferative breast 62 CIN3 62 transplantation HSCT 62 Wilms tumor 62 JAK inhibitors 62 lobular breast cancer 62 invasive candidiasis 62 Epstein Barr Virus EBV 62 macroalbuminuria 62 advanced adenomas 62 desmoplastic 62 malignant ovarian 62 mtDNA mutations 62 eccrine 62 intracranial hemorrhage ICH 62 TACI Ig 62 neurodegenerative disorder 62 diabetes mellitus DM 62 lipomas 62 autoantibody positive 62 riociguat 62 hypoperfusion 62 haematological cancers 62 NMIBC 62 metastatic bladder 62 Cell Lymphoma CTCL 62 EGFR mutation 62 arteriovenous malformations 62 cytoreduction 62 nonproliferative 62 autoimmune thyroid 62 HER2 expression 62 subependymal giant cell 62 atrial tachyarrhythmias 62 antitumour activity 62 neoadjuvant therapy 62 gastric carcinomas 62 ovarian breast 62 KRAS mutation 62 breast lesions 62 extracranial 62 lymphadenopathy 62 antibody mediated 62 Autoimmune disorders 62 hepatic metastases 62 radiographic findings 62 lupus nephritis 62 homozygous familial hypercholesterolemia 62 Synovial sarcoma 62 sarcoid 62 hematological disorders 62 QTc prolongation 62 Haptoglobin 62 osteochondromas 62 interstitial pneumonia 62 neuro degenerative disease 62 Th2 cytokines 62 HbF 62 relapsing remitting 62 carcinoid cancer 62 biliary cancer 62 pathological hallmark 62 cAMP signaling 62 EoE 62 AAT deficiency 62 pancreatic tumors 62 Soft tissue sarcomas 62 malignant neoplasms 62 T1DM 62 idiopathic PAH 62 malignant brain 62 metastatic GIST 62 Idiopathic pulmonary fibrosis 62 HeFH 62 ASCUS 62 hA# 62 advanced adenoma 62 chromosome aberrations 62 Hutchinson Gilford progeria 62 Zollinger Ellison syndrome 62 Gorlin syndrome 62 invasive carcinomas 62 steatohepatitis 62 HNSCC 62 elevated triglyceride levels 62 carcinomas 62 Adjuvant therapy 62 ErbB2 positive 62 epithelial ovarian cancer 62 Uterine fibroids 62 acute lymphoblastic 62 dermatofibrosarcoma protuberans 62 Hypotension 62 cirrhosis liver failure 62 Toxicities 62 esophageal squamous cell carcinoma 62 radioiodine therapy 62 antiproliferative effects 62 Neuroendocrine tumors 62 Chronic myeloid leukemia CML 62 IgG4 62 bullous 62 KRAS mutations 62 hypervascular tumors 62 cryptogenic 62 Heavy menstrual bleeding 62 Testicular cancer 62 chronic lymphocytic 62 PNH patients 62 precursor lesions 62 polycystic kidneys 62 liver scarring 62 pemphigus vulgaris 62 Idiopathic Pulmonary Fibrosis 62 haematological 62 sporadic ALS 62 cervical carcinoma 62 neurofibromatosis type 62 primitive neuroectodermal tumors 62 baseline LDH 62 lung nodules 62 transthyretin amyloidosis 62 proliferative diabetic retinopathy 62 cancer mCRC 62 axillary lymph nodes 62 IDH1 mutation 62 glioblastoma multiforme GBM 62 prostate epithelial cells 62 autoimmune pancreatitis 62 invasive carcinoma 62 biologic pathways 62 anti angiogenic therapy 62 interleukin IL -# 62 Hereditary angioedema HAE 62 idiopathic pulmonary fibrosis IPF 62 osteopetrosis 62 Neurofibromatosis type 62 liver transplant recipients 62 cytoreductive surgery 62 chronic GVHD 62 Chronic lymphocytic leukemia CLL 62 chemoembolization 62 squamous carcinoma 62 OHR/AVR# 62 castration resistant prostate cancer 62 remyelination 62 ximelagatran 62 metastatic prostate 62 Glioblastomas 62 CMV disease 62 Chronic HCV 62 trial evaluating PRX# 61 adrenalectomy 61 lymph node enlargement 61 hypercalcemia 61 autologous transplants 61 immunodeficiencies 61 localized renal 61 esophageal gastric 61 EGFRIs 61 Tarvacin 61 recurrent NSCLC 61 Surgical resection 61 pT2 61 uveal melanoma 61 childhood acute lymphoblastic 61 metastatic bone 61 hyperalgesia 61 galiximab 61 TGFBR1 * 6A 61 N. gonorrhoeae 61 adriamycin 61 catheter angiography 61 aortic valve stenosis 61 enzastaurin 61 intensive statin therapy 61 mesothelin 61 pancytopenia 61 microvascular disease 61 Chronic myeloid leukemia 61 nonischemic 61 stress cardiomyopathy 61 cytogenetic responses 61 pleural fluid 61 ischemic lesions 61 hemolytic anemia 61 Malignant mesothelioma 61 pancreatic lung 61 hormone refractory 61 WT1 61 situ LCIS 61 angiogenesis inhibition 61 cerebral vasospasm 61 neovascularization 61 Myasthenia gravis 61 non squamous 61 indolent lymphoma 61 Takotsubo cardiomyopathy 61 underlying pathophysiology 61 tumor subtypes 61 circulating endothelial cells 61 fatal neurodegenerative disorder 61 chemoresistant 61 clinicopathological 61 imatinib resistant 61 sJIA 61 Doxil ® 61 squamous cell 61 histologically 61 normal karyotype 61 B Cell Lymphoma 61 GPC5 61 heavily pretreated 61 gastrointestinal stromal tumors GISTs 61 Hypertrophy 61 neuroblastoma tumor 61 acute aortic dissection 61 allograft rejection 61 pathogenic mechanisms 61 N Myc 61 systemic mastocytosis 61 squamous cell cancers 61 lymphomas leukemias 61 Epstein Barr Virus 61 curative resection 61 bronchoalveolar 61 HER2 positive breast 61 ischemic cardiomyopathy 61 cerebral angiography 61 tumor xenograft models 61 glioblastoma tumor 61 nonmalignant 61 autosomal dominant polycystic kidney 61 bladder carcinoma 61 pancreatic prostate 61 thoracic aortic aneurysm 61 endocrine therapies 61 hyperplasia 61 osteoid osteoma 61 Tumor shrinkage 61 xenograft models 61 DIPG 61 thromboembolic disease 61 Lymphocytic 61 Idiopathic Pulmonary Fibrosis IPF 61 Prostatitis 61 somatostatin receptors 61 CMV infections 61 autoinflammatory diseases 61 gadolinium enhanced 61 MMP inhibitors 61 distant metastases 61 papillary RCC 61 diffuse gastric 61 taxane therapy 61 Chronic Myelogenous Leukemia 61 fibromatosis 61 myasthenia gravis MG 61 cardiac troponin 61 invasive ductal breast cancer 61 BRAF gene 61 phenotypic expression 61 Sarcomas 61 Adenocarcinoma 61 pituitary adenoma 61 glioblastomas 61 BRCA deficient 61 spontaneous regression 61 relapsed SCLC 61 tumors GIST 61 adenocarcinoma 61 thalidomide Thalomid 61 lung adenocarcinoma 61 biochemical abnormalities 61 plasma kallikrein 61 choroidal vasculopathy 61 pulmonary hypertension PH 61 cortical dysplasia 61 Inflammatory bowel disease 61 endophthalmitis 61 Peripheral neuropathy 61 Opportunistic infections 61 MAGE A3 61 Diffuse Large B 61 T#I [002] 61 epithelial ovarian 61 lesional 61 obstructive coronary 61 metastatic kidney 61 Neuropathic pain 61 chronic rhinosinusitis 61 Leukemia lymphoma 61 lysosomal storage diseases 61 colorectal neoplasms 61 rFVIIa 61 chemo resistant 61 osteoblastic 61 androgen deprivation 61 Moyamoya disease 61 thrombocytopenic 61 purpura 61 gynecologic malignancy 61 Atypical Hemolytic Uremic Syndrome 61 papillomatosis 61 pDCs 61 hypervascular 61 FGFR1 61 systemic autoimmune 61 virologic responses 61 resectable 61 carcinomatosis 61 cholestasis 61 idiopathic pulmonary 61 demonstrated antitumor activity 61 LQTS 61 osteoid 61 soft tissue sarcomas 61 hyperoxaluria 61 NAbs 61 genetic syndromes 61 intracerebral haemorrhage 61 COX2 61 gastrointestinal reflux 61 superficial basal cell carcinoma 61 Naive Patients 61 coronary vessels 61 genetic aberrations 61 tyrosine kinase inhibitors TKIs 61 hepatitis C genotype 61 NF kB pathway 61 malignant transformation 61 systemic fungal infections 61 diagnostic biomarker 61 Zollinger Ellison Syndrome 61 chromosomal mutations 61 basal cell cancers 61 interstitial lung disease 61 stratifying patients 61 prophylactic cranial irradiation 61 transgenic rats 61 NF1 61 AML acute myeloid 61 lymphoid tumors 61 infiltrative 61 chronic periodontitis 61 chronic hepatitis cirrhosis 61 hepatic cirrhosis 61 carotid stenosis 61 Malignant Melanoma 61 tumor recurrence 61 severe malignant osteopetrosis 61 haematopoietic 61 ERK signaling 61 neovascular 61 bacterium Neisseria meningitidis 61 pathogenic mutations 61 kinase inhibition 61 etiologies 61 perfusion defects 61 de novo lesions 61 bleomycin 61 Benign breast 61 malignancy 61 JAK STAT pathway 61 Surgical excision 61 genetic polymorphisms 61 fallopian tube carcinoma 61 brain metastases 61 atherothrombosis 61 situ CIS 61 Gastric cancer 61 myelogenous leukemia 61 pretransplant 61 pan HDAC inhibitor 61 trans retinoic acid 61 Leber congenital amaurosis LCA 61 delafloxacin 61 Symadex 61 dysplastic lesions 61 nutlin 3a 61 Parkinsonian Syndromes 61 endometrioid 61 uricase 61 Radioimmunotherapy 61 hormone receptor negative 61 multisystem disease 61 interferon γ 61 fronto temporal dementia 61 CDH1 61 imatinib resistance 61 T1c 61 neurologic symptoms 61 diabetic kidney 61 bridging fibrosis 61 Adjuvant chemotherapy 61 Osteosarcoma 61 ara C 61 Mesenchymal 61 hepatoma 61 myeloma cells 61 renovascular hypertension 61 microvascular endothelial cells 61 ptau 61 engineered RAP peptides 61 Natalizumab 61 ALT flares 61 aplasia 61 mouse xenograft models 61 Trastuzumab 61 Acute Myelogenous Leukemia 61 EXJADE 61 neoplastic diseases 60 Diabetic nephropathy 60 trabectedin 60 EUS FNA 60 varicella infection 60 peritoneal cancer 60 gastroesophageal junction 60 Vandetanib 60 PsA 60 testicular tumors 60 FSGS 60 primitive neuroectodermal tumor 60 atrophic gastritis 60 oesophageal adenocarcinoma 60 somatic mutations 60 fluconazole resistant 60 Von Willebrand disease 60 homozygous FH 60 chronic eosinophilic leukemia 60 generalized seizures 60 EGF receptor 60 ceroid lipofuscinosis NCL 60 Severe Primary IGFD 60 FDG PET imaging 60 squamous cell cancer 60 coagulopathy 60 immunosuppressive therapies 60 missense mutations 60 fibrin deposition 60 neovascular diseases 60 cytologically 60 Endometrial 60 superficial bladder cancer 60 interferon beta therapy 60 lupus scleroderma 60 FLT3 ITD 60 demyelinating diseases